Dorui Pharmaceuticals (301075.SZ) released its report for the first quarter of 2024, with revenue of 784.574 million...
According to the Zhitong Finance App, Dorui Pharmaceutical (301075.SZ) released its report for the first quarter of 2024, with operating income of 784.574 million yuan, up 0.48% year on year; net loss attributable to shareholders of listed companies was 2,5373 million yuan, up 4.97% year on year; net loss attributable to shareholders of listed companies after deducting non-recurring profit and loss was 3.7493 million yuan, up 1.4% year on year; basic loss per share was 0.03 yuan/share.